The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Body Clock Genes Tied to Prostate Radiotherapy Toxicity
2.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
3.
A radiotheranostic approach designed to combat aggressive cancers
4.
New guidelines expand access to lung cancer screening, but gaps remain in reaching rural and uninsured populations
5.
Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.
1.
Risk Assessment of Functional Vulnerability During Long-Term Cancer Survivorship
2.
Progressive Models in Hematology for Healthcare Excellence
3.
Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role
4.
Integrated Strategies in Oncology for Modern Medicine
5.
Targeted Degraders for Lymphoma: Mechanisms, Clinical Implications, and Emerging Therapies
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Should We Use DARA Up Front As First-Line Therapy in MM?
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation